合佳医药 (838641.OC)

+ 收藏

财务摘要(报告期)(合佳医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报2022年一季报
每股指标:
 每股收益 - 基本(元) 0.440.210.450.220.07
 每股收益 - 稀释(元) 0.400.210.450.220.07
 每股收益 - 期末股本摊薄(元) 0.410.180.450.220.07
 每股净资产BPS(元) 6.426.185.995.765.60
 每股经营活动产生的现金流量净额(元) 0.280.080.950.02-0.14
 每股营业收入(元) 5.402.315.392.861.38
关键比率:
 净资产收益率 - 摊薄(%) 6.432.877.573.831.17
 净资产收益率 - 加权(%) 7.023.407.863.911.18
 净资产收益率 - 平均(%) 7.433.277.873.911.18
 净资产收益率 - 扣除(%) 5.892.647.643.971.33
 总资产净利率 - 平均(%) 4.622.064.922.380.72
 总资产报酬率ROA(%) 6.402.826.693.201.19
 投入资本回报率ROIC(%) 6.833.067.473.611.30
 销售毛利率(%) 21.8120.6721.9121.4123.05
 销售净利率(%) 7.567.678.427.674.69
 资产负债率(%) 36.8335.8637.7840.3038.61
 资产周转率(倍) 0.610.270.580.310.15
 销售商品提供劳务收到的现金/营业收入(%) 86.2994.01106.7481.2486.52
 营业利润同比增长率(%) 16.15-2.6766.81151.54364.01
 营业收入同比增长率(%) 27.993.176.0936.4656.82
 利润总额同比增长率(%) 16.561.5167.17143.09307.59
 归属母公司股东的净利润同比增长率(%) 16.292.7976.50115.58238.81
 扣非后归属母公司股东的净利润同比增长率(%) 5.52-9.1083.79136.50365.46
 总资产同比增长率(%) 34.7327.529.3322.67-
 总负债同比增长率(%) 31.3613.4611.3156.69-
 净资产同比增长率(%) 36.8737.008.177.02-
利润表摘要:
 营业总收入(元) 945,885,012.18404,586,068.28739,038,868.62392,136,414.08189,025,309.08
 营业总成本(元) 861,945,669.33373,149,404.49675,485,878.32352,584,395.22176,546,064.60
 营业收入(元) 945,885,012.18404,586,068.28739,038,868.62392,136,414.08189,025,309.08
 营业利润(元) 85,838,666.5636,039,057.6673,905,743.3437,029,006.4312,557,968.24
 利润总额(元) 85,444,042.9636,050,381.9873,306,854.4935,515,489.5911,072,430.68
 净利润(元) 71,551,701.0031,018,180.4762,191,954.9430,063,259.808,860,168.82
 归属母公司股东的净利润(元) 72,297,002.0631,099,671.1062,171,379.9830,254,901.169,013,023.63
 非经常性损益(元) 6,055,529.562,585,523.27-603,860.42-1,112,621.61-1,201,086.52
 归属母公司股东的净利润扣除非经常性损益(元) 66,241,472.5028,514,147.8362,775,240.4031,367,522.7710,214,110.15
资产负债表摘要:
 流动资产(元) 926,693,130.78851,307,883.00753,950,570.15855,634,216.74784,129,401.89
 固定资产(元) 400,159,000.95418,015,522.78265,408,434.01322,031,266.17312,100,180.44
 资产总计(元) 1,779,190,471.681,687,001,826.891,320,601,352.671,322,882,378.541,251,144,766.09
 流动负债(元) 549,130,752.41510,452,677.93437,075,516.49472,881,325.56429,350,309.98
 非流动负债(元) 106,188,776.7494,458,722.2061,808,102.5460,265,525.8453,728,999.28
 负债合计(元) 655,319,529.15604,911,400.13498,883,619.03533,146,851.40483,079,309.26
 股东权益(元) 1,123,870,942.531,082,090,426.76821,717,733.64789,735,527.14768,065,456.83
 归属母公司股东的权益(元) 1,124,369,567.931,081,925,241.70821,471,057.94789,701,067.78767,992,210.95
 资本公积(元) 535,018,783.25535,018,783.25343,677,583.25343,677,583.25343,677,583.25
 盈余公积(元) 35,290,132.0330,267,122.5330,267,122.5323,858,141.6323,858,141.63
 未分配利润(元) 377,416,516.81341,242,195.35310,142,524.25284,635,026.33262,992,694.46
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 816,230,332.71380,352,666.81788,815,200.45318,552,659.22163,548,432.16
 经营活动产生的现金净流量(元) 48,761,150.3013,758,416.02129,854,289.262,232,911.02-18,760,775.32
 购建固定无形长期资产支付的现金(元) 48,941,550.2614,366,608.7546,286,235.0916,829,299.5022,513,572.07
 投资支付的现金(元) 49,650,000.0052,102,568.09102,000,000.0041,000,000.00-
 投资活动产生的现金净流量(元) -69,578,436.27-51,492,315.69-129,693,786.80-45,149,184.15-44,503,042.57
 取得借款收到的现金(元) 266,289,005.00160,275,567.00253,063,556.72127,349,092.0255,218,480.02
 筹资活动产生的现金净流量(元) 60,927,179.3143,943,081.78-9,166,775.8946,575,499.1121,907,824.66
 现金及现金等价物净增加(元) 41,627,544.097,338,988.86-6,776,086.604,274,426.43-41,614,923.78
 期末现金及现金等价物余额(元) 93,701,719.6059,413,164.3752,074,175.5163,124,688.5417,235,338.33
 折旧与摊销(元) 127,889,002.6622,154,673.6043,703,088.4922,837,465.69-
公告日期 2024-04-222023-08-232023-04-212022-08-242022-04-28
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院